LIVIVO - Search results -

Search results

Result 1 - 9 of total 9

Search options

Article ; Online: Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines.

Dos Santos, Wagner Gouvêa

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

2021 Volume 136, Page(s) 111272

Abstract: Coronavirus disease 19 (COVID-19) continues to challenge most scientists in the search of an effective way to either prevent infection or to avoid spreading of the disease. As result of global efforts some advances have been reached and we are more ... ...

Abstract	Coronavirus disease 19 (COVID-19) continues to challenge most scientists in the search of an effective way to either prevent infection or to avoid spreading of the disease. As result of global efforts some advances have been reached and we are more prepared today than we were at the beginning of the pandemic, however not enough to stop the transmission, and many questions remain unanswered. The possibility of reinfection of recovered individuals, the duration of the immunity, the impact of SARS-CoV-2 mutations in the spreading of the disease as well as the degree of protection that a potential vaccine could have are some of the issues under debate. A number of vaccines are under development using different platforms and clinical trials are ongoing in different countries, but even if they are licensed it will need time until reach a definite conclusion about their real safety and efficacy. Herein we discuss the different strategies used in the development of COVID-19 vaccines, the questions underlying the type of immune response they may elicit, the consequences that new mutations may have in the generation of sub-strains of SARS-CoV-2 and their impact and challenges for the efficacy of potential vaccines in a scenario postpandemic.
MeSH term(s)	COVID-19/prevention & control ; COVID-19/virology ; COVID-19 Vaccines/immunology ; Genetic Variation ; Humans ; Immunity, Humoral/genetics ; SARS-CoV-2/genetics
Chemical Substances	COVID-19 Vaccines
Language	English
Publishing date	2021-01-12
Publishing country	France
Document type	Journal Article ; Review
ZDB-ID	392415-4
ISSN	1950-6007 ; 0753-3322 ; 0300-0893
ISSN (online)	1950-6007
ISSN	0753-3322 ; 0300-0893
DOI	10.1016/j.biopha.2021.111272
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ud II Zs.198: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Natural history of COVID-19 and current knowledge on treatment therapeutic options.

Dos Santos, Wagner Gouvea

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

2020 Volume 129, Page(s) 110493

Abstract: Despite intense research there is currently no effective vaccine available against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 and responsible for the COVID-19 pandemic. This infectious and communicable ... ...

Abstract	Despite intense research there is currently no effective vaccine available against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 and responsible for the COVID-19 pandemic. This infectious and communicable disease has become one of the major public health challenges in the world. The clinical management of COVID-19 has been limited to infection prevention and control measures associated with supportive care such as supplemental oxygen and mechanical ventilation. Meanwhile efforts to find an effective treatment to inhibit virus replication, mitigate the symptoms, increase survival and decrease mortality rate are ongoing. Several classes of drugs, many of them already in use for other diseases, are being evaluated based on the body of clinical knowledge obtained from infected patients regarding to the natural history and evolution of the infection. Herein we will provide an updated overview of the natural history and current knowledge on drugs and therapeutic agents being tested for the prevention and treatment of COVID-19. These include different classes of drugs such as antiviral agents (chloroquine, ivermectin, nitazoxanide, hydroxychloroquine, lopinavir, remdesivir, tocilizumab), supporting agents (Vitamin C, Vitamin D, azithromycin, corticosteroids) and promising investigational vaccines. Considering the controversies and excessive number of compounds being tested and reported in the literature we hope that this review can provide useful and updated consolidated information on potential drugs used to prevent, control and treat COVID-19 patients worldwide.
MeSH term(s)	Animals ; Antiviral Agents/pharmacology ; Betacoronavirus/drug effects ; Betacoronavirus/isolation & purification ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/virology ; Drug Design ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Public Health ; SARS-CoV-2 ; Viral Vaccines/administration & dosage ; COVID-19 Drug Treatment
Chemical Substances	Antiviral Agents ; Viral Vaccines
Keywords	covid19
Language	English
Publishing date	2020-07-03
Publishing country	France
Document type	Journal Article ; Review
ZDB-ID	392415-4
ISSN	1950-6007 ; 0753-3322 ; 0300-0893
ISSN (online)	1950-6007
ISSN	0753-3322 ; 0300-0893
DOI	10.1016/j.biopha.2020.110493
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ud II Zs.198: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Natural history of COVID-19 and current knowledge on treatment therapeutic options

dos Santos, Wagner Gouvea

Biomedicine & Pharmacotherapy

2020 Volume 129, Page(s) 110493

Keywords	Pharmacology ; General Medicine ; covid19
Language	English
Publisher	Elsevier BV
Publishing country	us
Document type	Article ; Online
ZDB-ID	392415-4
ISSN	1950-6007 ; 0753-3322 ; 0300-0893
ISSN (online)	1950-6007
ISSN	0753-3322 ; 0300-0893
DOI	10.1016/j.biopha.2020.110493
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

In stock of ZB MED Cologne/Königswinter

Ud II Zs.198: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Natural history of COVID-19 and current knowledge on treatment therapeutic options

Dos Santos, Wagner Gouvea

Biomed Pharmacother

Abstract	Despite intense research there is currently no effective vaccine available against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 and responsible for the COVID-19 pandemic. This infectious and communicable disease has become one of the major public health challenges in the world. The clinical management of COVID-19 has been limited to infection prevention and control measures associated with supportive care such as supplemental oxygen and mechanical ventilation. Meanwhile efforts to find an effective treatment to inhibit virus replication, mitigate the symptoms, increase survival and decrease mortality rate are ongoing. Several classes of drugs, many of them already in use for other diseases, are being evaluated based on the body of clinical knowledge obtained from infected patients regarding to the natural history and evolution of the infection. Herein we will provide an updated overview of the natural history and current knowledge on drugs and therapeutic agents being tested for the prevention and treatment of COVID-19. These include different classes of drugs such as antiviral agents (chloroquine, ivermectin, nitazoxanide, hydroxychloroquine, lopinavir, remdesivir, tocilizumab), supporting agents (Vitamin C, Vitamin D, azithromycin, corticosteroids) and promising investigational vaccines. Considering the controversies and excessive number of compounds being tested and reported in the literature we hope that this review can provide useful and updated consolidated information on potential drugs used to prevent, control and treat COVID-19 patients worldwide.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #626324
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.

Montel, Aline Monezi / Dos Santos, Raquel Gouvêa / da Costa, Pryscila Rodrigues / Silveira-Lacerda, Elisângela de Paula / Batista, Alzir Azevedo / Dos Santos, Wagner Gouvêa

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

2017 Volume 30, Issue 2, Page(s) 295–305

Abstract: Novel metal complexes have received great attention in the last decades due to their potential anticancer activity. Notably, ruthenium-based complexes have emerged as good alternative to the currently used platinum-based drugs for cancer therapy, ... ...

Abstract	Novel metal complexes have received great attention in the last decades due to their potential anticancer activity. Notably, ruthenium-based complexes have emerged as good alternative to the currently used platinum-based drugs for cancer therapy, providing less toxicity and side effects to patients. Glioblastoma is an aggressive and invasive type of brain tumor and despite of advances is the field of neurooncology there is no effective treatment until now. Therefore, we sought to investigate the potential antiproliferative activity of phosphine-ruthenium-based complexes on human glioblastoma cell lines. Due to its octahedral structure as opposed to the square-planar geometry of platinum(II) compounds, ruthenium(II) complexes exhibit different structure-function relationship probably acting through a different mechanism from that of cisplatin beyond their ability to bind DNA. To better improve the pharmacological activity of metal complexes we hypothesized that neutron activation of ruthenium in the complexes would allow to decrease the effective concentration of the compound needed to kill tumor cells. Herein we report on the effect of unmodified and neutron activated phosphine ruthenium II complexes on glioblastoma cell lines carrying wild-type and mutated p53 tumor suppressor gene. Induction of apoptosis/authophagy as well as generation of reactive oxygen species were determined. The phosphine ruthenium II complexes tested were highly active against glioblastoma cell lines inducing cell death both through apoptosis and autophagy in a p53 independent fashion. Neutron activation of ruthenium compounds rendered them more active than their original counterparts suggesting a new strategy to improve the antitumor activity of these compounds.
Language	English
Publishing date	2017-04
Publishing country	Netherlands
Document type	Journal Article
ZDB-ID	1112688-7
ISSN	1572-8773 ; 0966-0844
ISSN (online)	1572-8773
ISSN	0966-0844
DOI	10.1007/s10534-017-0006-1
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 2515: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Simulations of complex and microscopic models of cardiac electrophysiology powered by multi-GPU platforms.

Gouvêa de Barros, Bruno / Sachetto Oliveira, Rafael / Meira, Wagner / Lobosco, Marcelo / Weber dos Santos, Rodrigo

Computational and mathematical methods in medicine

2012 Volume 2012, Page(s) 824569

Abstract: Key aspects of cardiac electrophysiology, such as slow conduction, conduction block, and saltatory effects have been the research topic of many studies since they are strongly related to cardiac arrhythmia, reentry, fibrillation, or defibrillation. ... ...

Abstract	Key aspects of cardiac electrophysiology, such as slow conduction, conduction block, and saltatory effects have been the research topic of many studies since they are strongly related to cardiac arrhythmia, reentry, fibrillation, or defibrillation. However, to reproduce these phenomena the numerical models need to use subcellular discretization for the solution of the PDEs and nonuniform, heterogeneous tissue electric conductivity. Due to the high computational costs of simulations that reproduce the fine microstructure of cardiac tissue, previous studies have considered tissue experiments of small or moderate sizes and used simple cardiac cell models. In this paper, we develop a cardiac electrophysiology model that captures the microstructure of cardiac tissue by using a very fine spatial discretization (8 μm) and uses a very modern and complex cell model based on Markov chains for the characterization of ion channel's structure and dynamics. To cope with the computational challenges, the model was parallelized using a hybrid approach: cluster computing and GPGPUs (general-purpose computing on graphics processing units). Our parallel implementation of this model using a multi-GPU platform was able to reduce the execution times of the simulations from more than 6 days (on a single processor) to 21 minutes (on a small 8-node cluster equipped with 16 GPUs, i.e., 2 GPUs per node).
MeSH term(s)	Algorithms ; Cardiac Electrophysiology/methods ; Computer Graphics ; Computer Simulation ; Electric Conductivity ; Finite Element Analysis ; Gap Junctions/physiology ; Heart/physiology ; Humans ; Markov Chains ; Models, Cardiovascular ; Models, Theoretical ; Myocardium/metabolism ; Software ; Time Factors
Language	English
Publishing date	2012-11-25
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2252430-7
ISSN	1748-6718 ; 1748-670X ; 1027-3662
ISSN (online)	1748-6718
ISSN	1748-670X ; 1027-3662
DOI	10.1155/2012/824569
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6373: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Simulations of Complex and Microscopic Models of Cardiac Electrophysiology Powered by Multi-GPU Platforms

Bruno Gouvêa de Barros / Rafael Sachetto Oliveira / Wagner Meira / Marcelo Lobosco / Rodrigo Weber dos Santos

Computational and Mathematical Methods in Medicine, Vol

2012 Volume 2012

Abstract	Key aspects of cardiac electrophysiology, such as slow conduction, conduction block, and saltatory effects have been the research topic of many studies since they are strongly related to cardiac arrhythmia, reentry, fibrillation, or defibrillation. However, to reproduce these phenomena the numerical models need to use subcellular discretization for the solution of the PDEs and nonuniform, heterogeneous tissue electric conductivity. Due to the high computational costs of simulations that reproduce the fine microstructure of cardiac tissue, previous studies have considered tissue experiments of small or moderate sizes and used simple cardiac cell models. In this paper, we develop a cardiac electrophysiology model that captures the microstructure of cardiac tissue by using a very fine spatial discretization (8 μm) and uses a very modern and complex cell model based on Markov chains for the characterization of ion channel’s structure and dynamics. To cope with the computational challenges, the model was parallelized using a hybrid approach: cluster computing and GPGPUs (general-purpose computing on graphics processing units). Our parallel implementation of this model using a multi-GPU platform was able to reduce the execution times of the simulations from more than 6 days (on a single processor) to 21 minutes (on a small 8-node cluster equipped with 16 GPUs, i.e., 2 GPUs per node).
Keywords	Computer applications to medicine. Medical informatics ; R858-859.7
Subject code	612 ; 000
Language	English
Publishing date	2012-01-01T00:00:00Z
Publisher	Hindawi Limited
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Controle do tombamento de plântulas de beterraba e tomate pelo tratamento de sementes com quitosana Control of beet and tomato damping-off by seed treatment with chitosan

Sérgio Miguel Mazaro / Américo Wagner Júnior / Idalmir dos Santos / Idemir Citadin / Jean Carlo Possenti / Alfredo de Gouvêa

Pesquisa Agropecuária Brasileira, Vol 44, Iss 11, Pp 1424-

2009 Volume 1430

Abstract: O objetivo deste trabalho foi avaliar o efeito do tratamento de sementes, com o indutor de resistência quitosana, sobre o tombamento de plântulas de beterraba e tomate, e sua relação com alterações bioquímicas e a defesa vegetal. Cada parcela foi ... ...

Abstract	O objetivo deste trabalho foi avaliar o efeito do tratamento de sementes, com o indutor de resistência quitosana, sobre o tombamento de plântulas de beterraba e tomate, e sua relação com alterações bioquímicas e a defesa vegetal. Cada parcela foi representada por 25 sementes. Os tratamentos consistiram da imersão das sementes em quitosana nas concentrações de 0; 0,25; 0,5; 1; 2 e 4%. Posteriormente, as sementes foram semeadas em bandejas com o substrato infectado com Rhizoctonia sp., e mantidas em casa de vegetação por 14 dias. A quitosana induziu a resistência das plântulas de beterraba e tomate e reduziu a incidência de tombamento. As concentrações de 1,1 e 2,5% apresentaram maior eficiência na redução do tombamento, para as culturas da beterraba e tomate, respectivamente. O uso da quitosana induz o aumento na atividade da enzima fenilalanina amônia-liase (FAL) e interfere nas variáveis bioquímicas foliares de proteínas e açúcares totais e redutores. The objective of this study was to evaluate the effect of seed treatment using the resistance inductor chitosan to control damping-off in tomato and beet seedlings, and its relationship with plant biochemical alterations and plant protection. Each plot was represented by twenty-five seeds. Treatments consisted of seed immersion in a chitosan suspension at 0, 0.25, 0.5, 1, 2 and 4% concentrations. Seeds were then sowed in trays with a substrate infected with Rhizoctonia sp. and maintained in greenhouse conditions for 14 days. Chitosan induced seedling resistance and reduced damping-off. The 1.1 and 2.5% concentrations were more efficient in controling the damping-off for beet and tomato crops respectively. Chitosan increases the phenylalanine ammonialyase (PAL) activity and interferes with the total proteins and total and reduced sugars rates in the leaves.
Keywords	indução de resistência ; proteínas relacionadas à patogênese ; tombamento de plântulas ; systemic acquired resistance ; pathogenesis-related proteins ; damping-off ; Agriculture (General) ; S1-972
Language	English
Publishing date	2009-11-01T00:00:00Z
Publisher	Embrapa Informação Tecnológica
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Controle do tombamento de plântulas de beterraba e tomate pelo tratamento de sementes com quitosana

Mazaro, Sérgio Miguel(Universidade Tecnológica Federal do Paraná) / Wagner Júnior, Américo(Universidade Tecnológica Federal do Paraná) / Santos, Idalmir dos / Citadin, Idemir / Possenti, Jean Carlo(Universidade Tecnológica Federal do Paraná) / Gouvêa, Alfredo de(Universidade Tecnológica Federal do Paraná)

Pesquisa Agropecuária Brasileira

2009/11

Abstract	O objetivo deste trabalho foi avaliar o efeito do tratamento de sementes, com o indutor de resistência quitosana, sobre o tombamento de plântulas de beterraba e tomate, e sua relação com alterações bioquímicas e a defesa vegetal. Cada parcela foi representada por 25 sementes. Os tratamentos consistiram da imersão das sementes em quitosana nas concentrações de 0; 0,25; 0,5; 1; 2 e 4%. Posteriormente, as sementes foram semeadas em bandejas com o substrato infectado com Rhizoctonia sp., e mantidas em casa de vegetação por 14 dias. A quitosana induziu a resistência das plântulas de beterraba e tomate e reduziu a incidência de tombamento. As concentrações de 1,1 e 2,5% apresentaram maior eficiência na redução do tombamento, para as culturas da beterraba e tomate, respectivamente. O uso da quitosana induz o aumento na atividade da enzima fenilalanina amônia-liase (FAL) e interfere nas variáveis bioquímicas foliares de proteínas e açúcares totais e redutores.
Language	Portuguese
Document type	Article
ISSN	0100-204X
Database	AGRIS - International Information System for the Agricultural Sciences and Technology

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Inter-library loan at ZB MED